CA2071909A1 - Kit for use in diagnosing maladies - Google Patents
Kit for use in diagnosing maladiesInfo
- Publication number
- CA2071909A1 CA2071909A1 CA002071909A CA2071909A CA2071909A1 CA 2071909 A1 CA2071909 A1 CA 2071909A1 CA 002071909 A CA002071909 A CA 002071909A CA 2071909 A CA2071909 A CA 2071909A CA 2071909 A1 CA2071909 A1 CA 2071909A1
- Authority
- CA
- Canada
- Prior art keywords
- kit
- test
- receptacles
- blood
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Water Treatment By Sorption (AREA)
- Lock And Its Accessories (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
A kit (10) for use in diagnosing maladies includes a carrier (26) comprising a plurality of apertures (28) for holding at least one test receptacle (12), wherein the test receptacle (12) has a test substance disposed therein. Each test receptacle (12) has a different test substance, or combination of substances, therein.
The kit further includes at least one control receptacle (14). The number of control receptacles preferably relates to the number of tests to be performed, namely one control for every ten tests to be done, with a minimum of five. Preferably, the kit further includes a lysing agent for lysing blood diluent for diluting the volume of blood to be measured. The kit may also include at least one empty receptacle for use in cleaning the equipment used to perform the test.
The kit further includes at least one control receptacle (14). The number of control receptacles preferably relates to the number of tests to be performed, namely one control for every ten tests to be done, with a minimum of five. Preferably, the kit further includes a lysing agent for lysing blood diluent for diluting the volume of blood to be measured. The kit may also include at least one empty receptacle for use in cleaning the equipment used to perform the test.
Description
WO 91/09138 PCI`/US9~ 560 , . , - 2~7~9 KlT FOR USE IN DIAGNOSING MAI~DIES
CROSS~ ERENCE TO REI~Th'D APPLICATIONS
This application is a continuation-in-part of my co-pending application9 Sen No.363,854, filed June 9, 1989, which was a continuation of my earlier application, Ser. No.
902,313, filed August 28, 1986, now abandoned, which, in turn, was a continuation~
part of my still earlier application, Ser. No. 547,767, which has now issued as U.S. Pat.
No. 4,614,722, on September 30, 1986.
Additionally, this application is related to my earlier application, Ser. No.
913,940, now issued as U.S. Pat. No. 4,788,155, on November 29, 1988.
BAC~GROUND OF TE{E INVENIION
The present invention relates to a kit for use in diagnosing the presence or absence of maladies in a subject, and, more particularly, to a kit for use in performing the test described in my prior patents.
',' In my referenced prior patents, and my referenced co-pending application (the disclosures of which are incorporated herein by reference), I describe a novel method of diagnosing maladies in a subject, by means of comparing the numbers and size distributions of the subject's blood cells before and after exposure to a substance having a known relationship to the malady for which the subject is being tested.
For ease of description, I refer to my inventive test as being directed to the diagnosis of a presence or absence of a malady. It is intended, however, that that , .
:`' .
. ,............... , ~ , ~
: ~ , - . -, . ,:
~:
,, . . ; . :
.
WO 91/09138 PCr/US90/07560 f.,~
2~71~09 2 ~errn be interpreted in the broadest sense. The test may be used to ascertain the cause of a known malady. For example, a patient who is known to suffer from migraine headaches, may be said to have had a diagnosis already performed. However, my test may be used to ascertain the cause of the migraine, such as a food sensitivity.
S In this sense, then, the test may be used to diagnose a migraine as being a migraine caused by an allergic reaction to a food or a chemical ingested by the patient, as opposed to being a migraine resulting from some other cause.
It is considered urmecessary, in light of the lengthy description of the tests themselves contained in my earlier patents, to describe herein the steps of the test in 10 detail. It is sufficient to summarize that the patented tests describe a methodology for the reliable and objective determination of the presence or absence of a malady in a subject.
Broadly spealcing, this methodology includes the steps of:
(a) drawing a sample of the subject's blood;
(b) separating the sample into a plurality of separate volumes, each havmg approximately equal distributions of blood cells therein;
(c) exposing at least one (test) volume of the blood to a substance h~ng a predetermined relationship to the malady;
~` (d) measuring the number and/or size distribution of blood cells in a control `~ 20 volume of the subject's blood;
(e) permitting the blood in the test volume to react with the substance;
(f) measuring the number and/or size distribution of blood cells in the test volume after reaction has been given the opportunity to occur; and (g) comparing the control and test volume measurements to determine 25 thereby if the subject has the malady for which he or she is being tested.
Again, this is a brief description of the patented test, and reference is once more made to the disclosures of the referenced patents for detai]s thereof.
wo 91/09138 Pcr/us9o/o756o 3 2071~9 To date, however, there has been no effective and conveluent apparatus for performing the tests.
As the test has been performed heretofore, the user thereof was compelled to collect a multitude of receptacles, into each of which he would introduce a selected 5 test substance (except, of course, for the receptacles used for the control volurnes).
The test substance would be purchased separately, from a different vendor, and different types of test substances would have to be collected from different sources.
For example, food extracts could be purchased from certain sources, while monoclonal antibodies, used for testing for certain types of cancers, would have to be 10 collected from a different source.
Furthermore, while it was known that control samples were needed, it was not known how many samples were optirnal for given applications, and so it was uncertain how many control samples should be acquired.
There is therefore a need for a single source of the tools needed to perform 15 the described test, in its various forrns. ~ -QBJECIS AND SUMMARY OF T~IE INVENIION
Accordingly, it is an object of the invention to provide a kit for use inperforming a test for diagnosing maladies which overcomes the drawbacks of the prior - art.
' It is a further object of the invention to provide a kit which contains at leastone test receptacle and at least one control receptacle for use in performing a diagnosis for a malady.
., . ~ . ~
.;
.
.
wo 91 /os1 38 Pcr/us9oto7s6o 2~7~909 ~, ' It is a still further object of the invention to prov~de a kit for use in diagnosing maladies which includes a number of control samples for performing a broader range of tests for different maladies.
Brie9y stated, there is provided a kit for use in diagnosing maladies that includes 5 at least one test receptacle, having a test substance disposed therein. Each test receptacle has a different test substance, or combination of test substances, therein.
The kit further includes at least one control receptacle. The nurnber of controlreceptacles preferably relates to the number of tests to be performed, namely one control for every ten tests to be done, with a minimum of five. Preferably, the kit 10 further includes a Iysing agent for Iysing blood cells which are not used as part of the test to be performed, and a blood diluent for dilutirlg the volume of blood to be measured. The kit may also include at least one empty receptacle for use in cleaning the equipment used to perform the test, and a carrier to hold the various components of the kit together for ease of transportation.
,;:
In accordance with these and other objects of the invention, there is provided a kit for use in diagnosing the presence or absence of a malady in a subject, the kit comprising: a firse, test, receptacle; a test substance disposed within the first receptacle9 the test substance having a predetermincd relationship with the malady; and a second, control, receptacle; whereby separate volumes of the subject's blood may be placed into 20 the first and second receptacles, for measuring the degree of reaction between the test substance arld the blood of the subject.
According eo a feature of the invention, there is further provided a kit for usein diagnosing the presence or absence of maladies in a subject, the kit comprising: a first plurality of first, test, receptacles; a second plurality of test substances, at least 25 one of the test substances being disposed in each of the first plurality of the first receptacles, each of the plura]ity of test substances having a predetermined relationship with at least one malady; and a second, control, receptacle; whereby separate volumes of the subject's blood may be placed into each of the plurality of the first receptacles ~ . .
:, .
.,~ .
.;~ ' . ' .
'::
WO 91/09138 PCr/US90~1i756Q
~- !
s ` 207~909 and the second receptacle, for measuring the degree of reaction between each of the test substances and the blood of the subject.
According to a still further feature of the invention, there is still further provided a kit ~or use in diagnosing the presence or absence of maladies in a subject, the ldt S comprising: a first plurality of first, test, receptacles; a second plurality of test substances, at least one of the test substances being disposed in each of the first plurality of the first receptacles, each of the plurality of test substances having a predetermined relationship with at least one malady; and at least five control receptacles; a third, cleaning, receptacle, for cleaning equipment used in perfolming 10 the diagnoses; a blood diluent for diluting the blood of the subject during the diagnoses;
and a Iysing agent, for Iysing blood cells in the blood of the subject; wherein the kit includes at least one control receptacle for each ten of the first receptacles; whereby separate volumes of the subject's blood may be placed into each of the plurality of the first receptac}es and the control receptacles, for measuring the degree of reacJdon 15 between each of the test substances and the blood of the subject.
The above, and other objects, features and advantages of the present inven~ion will become apparent from the following description read in conjunction wi~h ~e accompanying drawings, in which li~e reference numerals designate the same elements.
.
; BRIEF DESCRIPTION OF T~IE DRAWINGS
Fig. 1 is a perspective showing the various elements of the inventive kit.
:
Fig. 2 is an e~loded perspective showing a single receptacle of the kit of Fig.
1.
Fig. 3 is a perspective of a secondary embodiment of the inventive kit.
.
.~' ' ` ' . .
, .
- .
WO 9l/09138 PCr/US9~7S6~
~7~U~3 6 DETAILED DESCRIPrION OF TlIE PREFERRhl) EMBODIMENT
Referring now to Fig. 1, there is shown, generally at 10, a kit for use ~n diagnosing maladies in a-subject, in accordance with the invention.
In its simplest form, kit 10 includes a plurality of test receptacles 12~ and a S second plurality of control receptacles 14. Test receptac]es 12 and control receptacles 14 differ not at all, except in their respective contents. They are each sealed receptacles made of any sturdy and durable material, such as polystyrene. ~
exemplary receptacle is shown in Fig. 2, generally at 16.
.
Receptacle 16 includes a generally cylindrical body 18, and a lid 20. When 10 receptacle 16 is closed, it will be secure against outside contaminants. This will preserve the integrity of receptacle 16. Receptacle 16 also preferably includes a label 22, for identifying contents 24 thereof, i.e. whether it is a test receptacle (such as pictured, where the test substance is a food extract for corn), or a control receptacle, in which case contents 24 will be neutral.
- . j Returning now to Fig. 1, kit 10 further preferably includes a carrier 26, havinga plurality of apertures 2~ for retaining test receptacles 12 and control receptacles 14.
Carrier 26 may be made of any suitable material for holding test receptacles 12 and control receptacles 14, and its mode of manufacture w~l be appreciated bythose of ordinary skill in the art.
The difference between test receptacle 12 and control receptacles 14 is solely in their respective contents (24 in Fig. 2).
Into each test receptacle 12, a suitable test substance will be placed as its contents (see 24 in Fig. 2). The nature of contents 24 will depend on the type of .
WO 91/0sl38 PCr/US90/07560 2~7~09 malady tO be diagnosed with that par~icular test receptacle. As described in thereferenced patents, a test may be made for a particular malady in different ways, for example, by addmg a suspected reaction-provoking substance (e.g. a suspected food allergen, or a suspected chemical to which the subject is perhaps sensitive) or an S antibody specific to that malady (e.g. a monoclonal antibody specific to a cancer for which the subject is tested). For a more detailed discussion of the nature of the reaction which is to be measured by the test, reference is made to U.S. Pat. No.4,778,155, col. 9, line 27- col. 10, line 5. It will also be appreciated that ~he predetermined relationship may be that a ttest substance may cause a reaction, and 10 the test may be performed, then, to determine if the test substance in fact has caused the suspected reaction.
The manner in which any particular substance is to be placed into a test receptacle 12 will depend on the nature of the substance. For example, where thetest substance is to be a food extract, or a mold, to test for an allergic reaction to the 15 food, very little extract (on the order of a few milligrams) is needed to perform the test effective~y. This amount of material is difficult to handle, and so it is preferred that the test substance be carried on a carrier medium. This preference is compounded, m that the extract should be in a stable state, i.e. non-reactive with the emirorime~9 particularly with respect to moisture and/or air.
A stable test substance may be fabricated by preparing a solution containing the extract and a suspension medium, such as a rnixture of equal parts glycerine and water. rhe preferred solution would have one part extract to nine parts suspension medium by weight. Once the solution is mixed, appraq~imately 10 microliters of the - solution is delivered to the carrier, which in this embodiment is preferabb a nylon disk.
. .
The disk is then rapidly frozen. At that point, the liquid portion of the solution, in the form ~f ice, is removed by sublimation, under a high vacuurn, at a low temperature, appx. 50 degrees below zero Celsius.
~ .
,.
:. . ' ' . ' :
wo 9l/0~138 Pcr/~s~oi~756~ 1 2 0 7 ~ 9 8 It is here noted that this method of manufacture is specific to the case of foodextracts In the case of other types of test substances, the general procedure-would be the same, but the precise proportions of test substance to suspension medium may differ. That would be a matter of some minor experimentation, well within the scope 5 of one of ordinary skill.
It is here also explicitly noted that the test substance need not be a ~re substance. For example, it may be desired to test for reactions caused by a combination of medications in a patient, and so the test substance could be a combination of the two (or more) medicines.
It will also be appreciated that this is but one method of preparing test receptacles 12. It would be possible to carry test substances on any suitable, neutral7 medium, such as a plastic pellet, or even on the floor of the receptacle itself, if the receptacle is so formed as to permit such manufacture. Those of ordinary skill in the art will appreciate that the mode of manufacture of test receptacles 12 and control 15 receptacles 14 will be strictly a matter of design choice, within the purview of such an ordinarily slcilled person. It will be further appreciated that the precise details of ~e shape and construction of test and control receptacles 12 and 14, respectively, will depend on the intended application. The receptacles must conform to the intendeduse.
This, too, is a minor design choice, which those of ordinary sldll will be able to deterrnine for their intended use.
An important factor in the manufacture of kit 10 is that the contents of each test receptacle 12 and control receptacle 14 should be identical, but for the inclusion of the test substance in the test receptacle. In other words, even though the test ; 25 substance is ca~ried on a carrier medium which is believed to be neutral with respect to the subject's blood, that carrier medium should also be placed in control receptacles ., ' , : , .
. . -wo 9~/09138 pcrtuss~ 56~
9 -` ` - 2~7~9~9 14 as well, in case there is any reaction between that medium and the subject's blood.
Additionally, it assists in avoiding any potential problem in measurement, by ensuring that the volume of material in each type of receptacle is identical.
As to the relative number of test and control receptacles 12 and 14, respectively~
5 it is preferred that at least five control samples be used. In practice, different tests are performed sequentially, not in parallel. This means that each measurement is performed at a slightly different time. Where a number of tests are to be perfonned, possibly over one hundred in some instances, the difference in time between the first measurement and the final measurement could be as much as an hour or more. If the 10 control specimen is analyzed first, it may have different characteristics than if it were measured last, since, even in a non-reactive situation, a small percentage of blood cells of some patients, in certain instances may deteriorate over time.
Furthermore, it is now preferred that the comparisons be made on the basis of correlation to a standard deviation from the expected results, and the use of an average 15 of several control samplings renders a more accurate result.
These reasons for false readings may be avoided by use of several eorl~rol samples. For example, if control samples are prepared at different intervals, and the test samples are compared with the contrd sample nearest in time, then more accurate readings are possible. Furthermore, since the test results are comparative, an average 20 of several control readings may provide a better average of test results, leading to more accurate readings.
~ After experimentation, it has been determined that, in the currently preferred - testing protocol, at least one control measurement should be taken for every ten tests performed, with a minimum of five control samples. This may differ when, over time, 2S different equipment becomes available vith either greater accuracy, or greater speed, - so that deterioration becomes less of a factor.
, ...... ` ' . ., ' ' ' .. ':~''' . ' ..
. . - . . - ~:
. . .
.
. . . ~ .
wo 9l/09138 Pcr/uS9û~7~
20719~ lO ``
The above description details one preferred embodiment of the invention, name]y where the inventive kit includes only test receptacles and control receptacles, carried in a carner. In some applications, however, it may be also preferred to have other items be made a part of kit 10.
S Figure 3 illustrates a supplemental kit, shown generally at 30, which illustrates the additional items which may be a part of the inventive kit.
i It may be preferred that supplemental kit 30 be af~xed to kit 10, and it may be so manufactured. Here, for simplicity of illustration, it is shown separately.
Supplemental kit 30 includes a set of blank receptacles 32, for use in cleaning 10 equipment used to perforrn the diagnoses, a lysing agent 34 and a blood diluent 36 all carried in a carrier 38, having apertures 40.
Blank receptacles 32 may be used for cleaning the equipment used for performing the diagnosis. As will be readily appreciated, the performance of any teslt involving medical diagnoses must be done carefully, and so the equipment used mus~
15 be regularly msintained. Blank receptacles 32 may be used for carrying- detergen~s ~o ` place them in the equipment for cleaning, and then carrying the detergents away after cleaning.
As noted, in some applications it is necessary to Iyse certain blood cells so that measurements may be made. In these applications, lysing agent 34 would be useful.
20 It is preferred that the active lysing agent (for example, Saponin, from Sigma Chemical Co.) be present in a one-per cent solution in bacteriostatic water, in an amountsufficient to perform the tests to be made. Precise measurements may be made in accordance with the protocols set forth in my U.S. patents referenced above.
.
': .
'.' ' .: : .
... . . .
.,: .
wo 91/09138 PCI/US9Oi!~7S~a~
2~7~
It will also be noted that the type of lysing agent will depend on the type of blood cell to be Iysed, since different measurements may be taken of different types of cel~s, i.e. red blood cells, white blood cells or platelets.
Similarly, since a blood diluent is used in most applications, it is also pre~erred S that supplemental kit 30 include blood diluent 36, which is preferably a substance which is non-reactive with human blood, and is pH balanced to the acid level of human blood (7.4). Suitable solutions would be a mixture of buffered normal saline, 0.9% sodium chloride buffered to (appx.) pH 7.4 with sodium bicarbonate. The total volume ofblood diluent 36 provided would depend on the number of tests (and controls) tG be 10 performed, and so will depend on the particular application contemplated for any kit I0 and supplemental kit 30.
The collection of parts described above will permit the efficient and accurate performance of my patented test, by providing, for the first time, all of the components needed to perform the test.
I5 Having descn~ed preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited ~o klawe precise embodiments, and that various changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the invention as defined in the appended claims.
;'. ~ ' ~ , . . : .
CROSS~ ERENCE TO REI~Th'D APPLICATIONS
This application is a continuation-in-part of my co-pending application9 Sen No.363,854, filed June 9, 1989, which was a continuation of my earlier application, Ser. No.
902,313, filed August 28, 1986, now abandoned, which, in turn, was a continuation~
part of my still earlier application, Ser. No. 547,767, which has now issued as U.S. Pat.
No. 4,614,722, on September 30, 1986.
Additionally, this application is related to my earlier application, Ser. No.
913,940, now issued as U.S. Pat. No. 4,788,155, on November 29, 1988.
BAC~GROUND OF TE{E INVENIION
The present invention relates to a kit for use in diagnosing the presence or absence of maladies in a subject, and, more particularly, to a kit for use in performing the test described in my prior patents.
',' In my referenced prior patents, and my referenced co-pending application (the disclosures of which are incorporated herein by reference), I describe a novel method of diagnosing maladies in a subject, by means of comparing the numbers and size distributions of the subject's blood cells before and after exposure to a substance having a known relationship to the malady for which the subject is being tested.
For ease of description, I refer to my inventive test as being directed to the diagnosis of a presence or absence of a malady. It is intended, however, that that , .
:`' .
. ,............... , ~ , ~
: ~ , - . -, . ,:
~:
,, . . ; . :
.
WO 91/09138 PCr/US90/07560 f.,~
2~71~09 2 ~errn be interpreted in the broadest sense. The test may be used to ascertain the cause of a known malady. For example, a patient who is known to suffer from migraine headaches, may be said to have had a diagnosis already performed. However, my test may be used to ascertain the cause of the migraine, such as a food sensitivity.
S In this sense, then, the test may be used to diagnose a migraine as being a migraine caused by an allergic reaction to a food or a chemical ingested by the patient, as opposed to being a migraine resulting from some other cause.
It is considered urmecessary, in light of the lengthy description of the tests themselves contained in my earlier patents, to describe herein the steps of the test in 10 detail. It is sufficient to summarize that the patented tests describe a methodology for the reliable and objective determination of the presence or absence of a malady in a subject.
Broadly spealcing, this methodology includes the steps of:
(a) drawing a sample of the subject's blood;
(b) separating the sample into a plurality of separate volumes, each havmg approximately equal distributions of blood cells therein;
(c) exposing at least one (test) volume of the blood to a substance h~ng a predetermined relationship to the malady;
~` (d) measuring the number and/or size distribution of blood cells in a control `~ 20 volume of the subject's blood;
(e) permitting the blood in the test volume to react with the substance;
(f) measuring the number and/or size distribution of blood cells in the test volume after reaction has been given the opportunity to occur; and (g) comparing the control and test volume measurements to determine 25 thereby if the subject has the malady for which he or she is being tested.
Again, this is a brief description of the patented test, and reference is once more made to the disclosures of the referenced patents for detai]s thereof.
wo 91/09138 Pcr/us9o/o756o 3 2071~9 To date, however, there has been no effective and conveluent apparatus for performing the tests.
As the test has been performed heretofore, the user thereof was compelled to collect a multitude of receptacles, into each of which he would introduce a selected 5 test substance (except, of course, for the receptacles used for the control volurnes).
The test substance would be purchased separately, from a different vendor, and different types of test substances would have to be collected from different sources.
For example, food extracts could be purchased from certain sources, while monoclonal antibodies, used for testing for certain types of cancers, would have to be 10 collected from a different source.
Furthermore, while it was known that control samples were needed, it was not known how many samples were optirnal for given applications, and so it was uncertain how many control samples should be acquired.
There is therefore a need for a single source of the tools needed to perform 15 the described test, in its various forrns. ~ -QBJECIS AND SUMMARY OF T~IE INVENIION
Accordingly, it is an object of the invention to provide a kit for use inperforming a test for diagnosing maladies which overcomes the drawbacks of the prior - art.
' It is a further object of the invention to provide a kit which contains at leastone test receptacle and at least one control receptacle for use in performing a diagnosis for a malady.
., . ~ . ~
.;
.
.
wo 91 /os1 38 Pcr/us9oto7s6o 2~7~909 ~, ' It is a still further object of the invention to prov~de a kit for use in diagnosing maladies which includes a number of control samples for performing a broader range of tests for different maladies.
Brie9y stated, there is provided a kit for use in diagnosing maladies that includes 5 at least one test receptacle, having a test substance disposed therein. Each test receptacle has a different test substance, or combination of test substances, therein.
The kit further includes at least one control receptacle. The nurnber of controlreceptacles preferably relates to the number of tests to be performed, namely one control for every ten tests to be done, with a minimum of five. Preferably, the kit 10 further includes a Iysing agent for Iysing blood cells which are not used as part of the test to be performed, and a blood diluent for dilutirlg the volume of blood to be measured. The kit may also include at least one empty receptacle for use in cleaning the equipment used to perform the test, and a carrier to hold the various components of the kit together for ease of transportation.
,;:
In accordance with these and other objects of the invention, there is provided a kit for use in diagnosing the presence or absence of a malady in a subject, the kit comprising: a firse, test, receptacle; a test substance disposed within the first receptacle9 the test substance having a predetermincd relationship with the malady; and a second, control, receptacle; whereby separate volumes of the subject's blood may be placed into 20 the first and second receptacles, for measuring the degree of reaction between the test substance arld the blood of the subject.
According eo a feature of the invention, there is further provided a kit for usein diagnosing the presence or absence of maladies in a subject, the kit comprising: a first plurality of first, test, receptacles; a second plurality of test substances, at least 25 one of the test substances being disposed in each of the first plurality of the first receptacles, each of the plura]ity of test substances having a predetermined relationship with at least one malady; and a second, control, receptacle; whereby separate volumes of the subject's blood may be placed into each of the plurality of the first receptacles ~ . .
:, .
.,~ .
.;~ ' . ' .
'::
WO 91/09138 PCr/US90~1i756Q
~- !
s ` 207~909 and the second receptacle, for measuring the degree of reaction between each of the test substances and the blood of the subject.
According to a still further feature of the invention, there is still further provided a kit ~or use in diagnosing the presence or absence of maladies in a subject, the ldt S comprising: a first plurality of first, test, receptacles; a second plurality of test substances, at least one of the test substances being disposed in each of the first plurality of the first receptacles, each of the plurality of test substances having a predetermined relationship with at least one malady; and at least five control receptacles; a third, cleaning, receptacle, for cleaning equipment used in perfolming 10 the diagnoses; a blood diluent for diluting the blood of the subject during the diagnoses;
and a Iysing agent, for Iysing blood cells in the blood of the subject; wherein the kit includes at least one control receptacle for each ten of the first receptacles; whereby separate volumes of the subject's blood may be placed into each of the plurality of the first receptac}es and the control receptacles, for measuring the degree of reacJdon 15 between each of the test substances and the blood of the subject.
The above, and other objects, features and advantages of the present inven~ion will become apparent from the following description read in conjunction wi~h ~e accompanying drawings, in which li~e reference numerals designate the same elements.
.
; BRIEF DESCRIPTION OF T~IE DRAWINGS
Fig. 1 is a perspective showing the various elements of the inventive kit.
:
Fig. 2 is an e~loded perspective showing a single receptacle of the kit of Fig.
1.
Fig. 3 is a perspective of a secondary embodiment of the inventive kit.
.
.~' ' ` ' . .
, .
- .
WO 9l/09138 PCr/US9~7S6~
~7~U~3 6 DETAILED DESCRIPrION OF TlIE PREFERRhl) EMBODIMENT
Referring now to Fig. 1, there is shown, generally at 10, a kit for use ~n diagnosing maladies in a-subject, in accordance with the invention.
In its simplest form, kit 10 includes a plurality of test receptacles 12~ and a S second plurality of control receptacles 14. Test receptac]es 12 and control receptacles 14 differ not at all, except in their respective contents. They are each sealed receptacles made of any sturdy and durable material, such as polystyrene. ~
exemplary receptacle is shown in Fig. 2, generally at 16.
.
Receptacle 16 includes a generally cylindrical body 18, and a lid 20. When 10 receptacle 16 is closed, it will be secure against outside contaminants. This will preserve the integrity of receptacle 16. Receptacle 16 also preferably includes a label 22, for identifying contents 24 thereof, i.e. whether it is a test receptacle (such as pictured, where the test substance is a food extract for corn), or a control receptacle, in which case contents 24 will be neutral.
- . j Returning now to Fig. 1, kit 10 further preferably includes a carrier 26, havinga plurality of apertures 2~ for retaining test receptacles 12 and control receptacles 14.
Carrier 26 may be made of any suitable material for holding test receptacles 12 and control receptacles 14, and its mode of manufacture w~l be appreciated bythose of ordinary skill in the art.
The difference between test receptacle 12 and control receptacles 14 is solely in their respective contents (24 in Fig. 2).
Into each test receptacle 12, a suitable test substance will be placed as its contents (see 24 in Fig. 2). The nature of contents 24 will depend on the type of .
WO 91/0sl38 PCr/US90/07560 2~7~09 malady tO be diagnosed with that par~icular test receptacle. As described in thereferenced patents, a test may be made for a particular malady in different ways, for example, by addmg a suspected reaction-provoking substance (e.g. a suspected food allergen, or a suspected chemical to which the subject is perhaps sensitive) or an S antibody specific to that malady (e.g. a monoclonal antibody specific to a cancer for which the subject is tested). For a more detailed discussion of the nature of the reaction which is to be measured by the test, reference is made to U.S. Pat. No.4,778,155, col. 9, line 27- col. 10, line 5. It will also be appreciated that ~he predetermined relationship may be that a ttest substance may cause a reaction, and 10 the test may be performed, then, to determine if the test substance in fact has caused the suspected reaction.
The manner in which any particular substance is to be placed into a test receptacle 12 will depend on the nature of the substance. For example, where thetest substance is to be a food extract, or a mold, to test for an allergic reaction to the 15 food, very little extract (on the order of a few milligrams) is needed to perform the test effective~y. This amount of material is difficult to handle, and so it is preferred that the test substance be carried on a carrier medium. This preference is compounded, m that the extract should be in a stable state, i.e. non-reactive with the emirorime~9 particularly with respect to moisture and/or air.
A stable test substance may be fabricated by preparing a solution containing the extract and a suspension medium, such as a rnixture of equal parts glycerine and water. rhe preferred solution would have one part extract to nine parts suspension medium by weight. Once the solution is mixed, appraq~imately 10 microliters of the - solution is delivered to the carrier, which in this embodiment is preferabb a nylon disk.
. .
The disk is then rapidly frozen. At that point, the liquid portion of the solution, in the form ~f ice, is removed by sublimation, under a high vacuurn, at a low temperature, appx. 50 degrees below zero Celsius.
~ .
,.
:. . ' ' . ' :
wo 9l/0~138 Pcr/~s~oi~756~ 1 2 0 7 ~ 9 8 It is here noted that this method of manufacture is specific to the case of foodextracts In the case of other types of test substances, the general procedure-would be the same, but the precise proportions of test substance to suspension medium may differ. That would be a matter of some minor experimentation, well within the scope 5 of one of ordinary skill.
It is here also explicitly noted that the test substance need not be a ~re substance. For example, it may be desired to test for reactions caused by a combination of medications in a patient, and so the test substance could be a combination of the two (or more) medicines.
It will also be appreciated that this is but one method of preparing test receptacles 12. It would be possible to carry test substances on any suitable, neutral7 medium, such as a plastic pellet, or even on the floor of the receptacle itself, if the receptacle is so formed as to permit such manufacture. Those of ordinary skill in the art will appreciate that the mode of manufacture of test receptacles 12 and control 15 receptacles 14 will be strictly a matter of design choice, within the purview of such an ordinarily slcilled person. It will be further appreciated that the precise details of ~e shape and construction of test and control receptacles 12 and 14, respectively, will depend on the intended application. The receptacles must conform to the intendeduse.
This, too, is a minor design choice, which those of ordinary sldll will be able to deterrnine for their intended use.
An important factor in the manufacture of kit 10 is that the contents of each test receptacle 12 and control receptacle 14 should be identical, but for the inclusion of the test substance in the test receptacle. In other words, even though the test ; 25 substance is ca~ried on a carrier medium which is believed to be neutral with respect to the subject's blood, that carrier medium should also be placed in control receptacles ., ' , : , .
. . -wo 9~/09138 pcrtuss~ 56~
9 -` ` - 2~7~9~9 14 as well, in case there is any reaction between that medium and the subject's blood.
Additionally, it assists in avoiding any potential problem in measurement, by ensuring that the volume of material in each type of receptacle is identical.
As to the relative number of test and control receptacles 12 and 14, respectively~
5 it is preferred that at least five control samples be used. In practice, different tests are performed sequentially, not in parallel. This means that each measurement is performed at a slightly different time. Where a number of tests are to be perfonned, possibly over one hundred in some instances, the difference in time between the first measurement and the final measurement could be as much as an hour or more. If the 10 control specimen is analyzed first, it may have different characteristics than if it were measured last, since, even in a non-reactive situation, a small percentage of blood cells of some patients, in certain instances may deteriorate over time.
Furthermore, it is now preferred that the comparisons be made on the basis of correlation to a standard deviation from the expected results, and the use of an average 15 of several control samplings renders a more accurate result.
These reasons for false readings may be avoided by use of several eorl~rol samples. For example, if control samples are prepared at different intervals, and the test samples are compared with the contrd sample nearest in time, then more accurate readings are possible. Furthermore, since the test results are comparative, an average 20 of several control readings may provide a better average of test results, leading to more accurate readings.
~ After experimentation, it has been determined that, in the currently preferred - testing protocol, at least one control measurement should be taken for every ten tests performed, with a minimum of five control samples. This may differ when, over time, 2S different equipment becomes available vith either greater accuracy, or greater speed, - so that deterioration becomes less of a factor.
, ...... ` ' . ., ' ' ' .. ':~''' . ' ..
. . - . . - ~:
. . .
.
. . . ~ .
wo 9l/09138 Pcr/uS9û~7~
20719~ lO ``
The above description details one preferred embodiment of the invention, name]y where the inventive kit includes only test receptacles and control receptacles, carried in a carner. In some applications, however, it may be also preferred to have other items be made a part of kit 10.
S Figure 3 illustrates a supplemental kit, shown generally at 30, which illustrates the additional items which may be a part of the inventive kit.
i It may be preferred that supplemental kit 30 be af~xed to kit 10, and it may be so manufactured. Here, for simplicity of illustration, it is shown separately.
Supplemental kit 30 includes a set of blank receptacles 32, for use in cleaning 10 equipment used to perforrn the diagnoses, a lysing agent 34 and a blood diluent 36 all carried in a carrier 38, having apertures 40.
Blank receptacles 32 may be used for cleaning the equipment used for performing the diagnosis. As will be readily appreciated, the performance of any teslt involving medical diagnoses must be done carefully, and so the equipment used mus~
15 be regularly msintained. Blank receptacles 32 may be used for carrying- detergen~s ~o ` place them in the equipment for cleaning, and then carrying the detergents away after cleaning.
As noted, in some applications it is necessary to Iyse certain blood cells so that measurements may be made. In these applications, lysing agent 34 would be useful.
20 It is preferred that the active lysing agent (for example, Saponin, from Sigma Chemical Co.) be present in a one-per cent solution in bacteriostatic water, in an amountsufficient to perform the tests to be made. Precise measurements may be made in accordance with the protocols set forth in my U.S. patents referenced above.
.
': .
'.' ' .: : .
... . . .
.,: .
wo 91/09138 PCI/US9Oi!~7S~a~
2~7~
It will also be noted that the type of lysing agent will depend on the type of blood cell to be Iysed, since different measurements may be taken of different types of cel~s, i.e. red blood cells, white blood cells or platelets.
Similarly, since a blood diluent is used in most applications, it is also pre~erred S that supplemental kit 30 include blood diluent 36, which is preferably a substance which is non-reactive with human blood, and is pH balanced to the acid level of human blood (7.4). Suitable solutions would be a mixture of buffered normal saline, 0.9% sodium chloride buffered to (appx.) pH 7.4 with sodium bicarbonate. The total volume ofblood diluent 36 provided would depend on the number of tests (and controls) tG be 10 performed, and so will depend on the particular application contemplated for any kit I0 and supplemental kit 30.
The collection of parts described above will permit the efficient and accurate performance of my patented test, by providing, for the first time, all of the components needed to perform the test.
I5 Having descn~ed preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited ~o klawe precise embodiments, and that various changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the invention as defined in the appended claims.
;'. ~ ' ~ , . . : .
Claims (20)
1. A kit for use in diagnosing the presence or absence of a malady in a subject, the kit comprising:
a first, test, receptacle;
a test substance disposed within said first receptacle, said test substance having a predetermined relationship with the malady; and a second, control, receptacle;
whereby separate volumes of the subject's blood may be placed into said first and second receptacles, for measuring the degree of reaction between said test substance and said blood of the subject.
a first, test, receptacle;
a test substance disposed within said first receptacle, said test substance having a predetermined relationship with the malady; and a second, control, receptacle;
whereby separate volumes of the subject's blood may be placed into said first and second receptacles, for measuring the degree of reaction between said test substance and said blood of the subject.
2. The kit of Claim 1, wherein said test substance is carried in a first volume of a first carrier medium.
3. The kit of Claim 2, wherein said second receptacle includes a second volume of a second carrier medium.
4. The kit of Claim 3, wherein said first and second carrier media are identical.
5. The kit of Claim 3, wherein said first and second volumes are identical.
6. The kit of Claim 1, further comprising:
a blood diluent, for diluting said blood of the subject.
a blood diluent, for diluting said blood of the subject.
7. The kit of Claim 1, further comprising:
a lysing agent, for lysing blood cells in said blood of the subject.
a lysing agent, for lysing blood cells in said blood of the subject.
8. The kit of Claim 1, further comprising:
a third, cleaning, receptacle, for use in cleaning equipment used to perform thediagnosis of the malady.
a third, cleaning, receptacle, for use in cleaning equipment used to perform thediagnosis of the malady.
9. The kit of Claim 1, further comprising:
means for carrying said first and second receptacles.
means for carrying said first and second receptacles.
10. A kit for use in diagnosing the presence or absence of maladies in a subject, the kit comprising:
a first plurality of first, test, receptacles;
a second plurality of test substances, at least one of said test substances being disposed in each of said first plurality of said first receptacles, each of said plurality of test substances having a predetermined relationship with at least one malady; and a third plurality of second, control, receptacles;
whereby separate volumes of the subject's blood may be placed into each of said first and second receptacles, for measuring the degree of reaction between each of said test substances and said blood of the subject.
a first plurality of first, test, receptacles;
a second plurality of test substances, at least one of said test substances being disposed in each of said first plurality of said first receptacles, each of said plurality of test substances having a predetermined relationship with at least one malady; and a third plurality of second, control, receptacles;
whereby separate volumes of the subject's blood may be placed into each of said first and second receptacles, for measuring the degree of reaction between each of said test substances and said blood of the subject.
11. The kit of Claim 10, wherein at least one of said test substances is carriedin a first volume of a first carrier medium.
12. The kit of Claim 11, wherein each of said second receptacles includes a second volume of a second carrier medium.
13. The kit of Claim 12, wherein said first and second carrier media are identical.
14. The kit of Claim 12, wherein said first and second volumes are identical.
15. The kit of Claim 10, further comprising:
a blood diluent, for diluting said blood of the subject.
a blood diluent, for diluting said blood of the subject.
16. The kit of Claim 10, further comprising:
a lysing agent, for lysing blood cells in said blood of the subject.
a lysing agent, for lysing blood cells in said blood of the subject.
17. The kit of Claim 10, further comprising:
a third, cleaning, receptacle, for use in cleaning equipment used to perform thediagnosis of the malady.
a third, cleaning, receptacle, for use in cleaning equipment used to perform thediagnosis of the malady.
18. The kit of Claim 10, further comprising:
means for carrying said first and second receptacles.
means for carrying said first and second receptacles.
19. The kit of Claim 10, wherein the kit includes at least one control receptacle for each ten of said test receptacles, with a minimum of five of said control receptacles.
20. A kit for use in diagnosing the presence or absence of maladies in a subject, the kit comprising:
a first plurality of test receptacles;
a second plurality of test substances, at least one of said test substances being disposed in each of said first plurality of said test receptacles, each of said plurality of test substances having a predetermined relationship with at least one malady; and at least five control receptacles;
a cleaning receptacle, for cleaning equipment used in performing the diagnoses;
a blood diluent for diluting the blood of the subject during the diagnoses; and a lysing agent, for lysing blood cells in the blood of the subject;
wherein the kit includes at least one control receptacle for each ten of said test receptacles, with a minimum of five of said control receptacles;
whereby separate volumes of the subject's blood may be placed into each of said plurality of said test receptacles and said control receptacles, for measuring the degree of reaction between each of said test substances and said blood of the subject.
a first plurality of test receptacles;
a second plurality of test substances, at least one of said test substances being disposed in each of said first plurality of said test receptacles, each of said plurality of test substances having a predetermined relationship with at least one malady; and at least five control receptacles;
a cleaning receptacle, for cleaning equipment used in performing the diagnoses;
a blood diluent for diluting the blood of the subject during the diagnoses; and a lysing agent, for lysing blood cells in the blood of the subject;
wherein the kit includes at least one control receptacle for each ten of said test receptacles, with a minimum of five of said control receptacles;
whereby separate volumes of the subject's blood may be placed into each of said plurality of said test receptacles and said control receptacles, for measuring the degree of reaction between each of said test substances and said blood of the subject.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45386989A | 1989-12-20 | 1989-12-20 | |
| US07/453,869 | 1989-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2071909A1 true CA2071909A1 (en) | 1991-06-21 |
Family
ID=23802401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002071909A Abandoned CA2071909A1 (en) | 1989-12-20 | 1990-12-20 | Kit for use in diagnosing maladies |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0506852A4 (en) |
| JP (1) | JPH05504404A (en) |
| AU (1) | AU7174391A (en) |
| BR (1) | BR9007927A (en) |
| CA (1) | CA2071909A1 (en) |
| FI (1) | FI922862A (en) |
| IE (1) | IE904616A1 (en) |
| NO (1) | NO922413L (en) |
| WO (1) | WO1991009138A1 (en) |
| ZA (1) | ZA9010284B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992001934A1 (en) * | 1990-07-17 | 1992-02-06 | Pasula Mark J | Blood testing apparatus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4174202A (en) * | 1977-11-28 | 1979-11-13 | The Dow Chemical Company | Kit and method for testing liquids for hydrogen sulfide content |
| US4303610A (en) * | 1980-05-19 | 1981-12-01 | Pennzoil Company | Test kit for field analysis of plant tissue magnesium and calcium |
| US4614722A (en) * | 1983-11-01 | 1986-09-30 | Pasula Mark J | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies |
-
1990
- 1990-12-20 JP JP91502890A patent/JPH05504404A/en active Pending
- 1990-12-20 AU AU71743/91A patent/AU7174391A/en not_active Abandoned
- 1990-12-20 IE IE461690A patent/IE904616A1/en not_active Application Discontinuation
- 1990-12-20 CA CA002071909A patent/CA2071909A1/en not_active Abandoned
- 1990-12-20 ZA ZA9010284A patent/ZA9010284B/en unknown
- 1990-12-20 WO PCT/US1990/007560 patent/WO1991009138A1/en not_active Application Discontinuation
- 1990-12-20 BR BR909007927A patent/BR9007927A/en unknown
- 1990-12-20 EP EP19910902518 patent/EP0506852A4/en not_active Withdrawn
-
1992
- 1992-06-18 FI FI922862A patent/FI922862A/en not_active Application Discontinuation
- 1992-06-19 NO NO92922413A patent/NO922413L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991009138A1 (en) | 1991-06-27 |
| IE904616A1 (en) | 1991-07-17 |
| NO922413D0 (en) | 1992-06-19 |
| JPH05504404A (en) | 1993-07-08 |
| NO922413L (en) | 1992-06-19 |
| ZA9010284B (en) | 1991-10-30 |
| EP0506852A1 (en) | 1992-10-07 |
| BR9007927A (en) | 1992-11-10 |
| AU7174391A (en) | 1991-07-18 |
| FI922862A0 (en) | 1992-06-18 |
| FI922862A (en) | 1992-06-18 |
| EP0506852A4 (en) | 1993-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6663831B2 (en) | “One-device” system for testing constituents in fluids | |
| US4979515A (en) | System for obtaining blood samples and submitting for testing of AIDS | |
| US6576193B1 (en) | Device and method for collecting and testing fluid specimens | |
| JP4889498B2 (en) | High-speed sample analysis and storage device and method of use | |
| CN105228749B (en) | Portable blood cell count monitor | |
| EP1751268B1 (en) | Microfluidic device and leucocyte antigen mediated microfluidic assay | |
| US4614722A (en) | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies | |
| Yunginger et al. | Studies on Alternaria allergens: II. Measurement of the relative potency of commercial Alternaria extracts by the direct RAST and by RAST inhibition | |
| HU206918B (en) | Analytical detecting instrument | |
| SULZER et al. | Indirect fluorescent antibody tests for parasitic diseases. IV. Statistical study of variation in the indirect fluorescent antibody (IFA) test for toxoplasmosis | |
| NO830732L (en) | PROCEDURE FOR DETECTING OR DETERMINING HISTAMINE IN HISTAMINE-CONTAINING MATERIALS, SPECIFIC BODIES AND ANALYTICAL AGENT FOR USE IN SUCH A PROCEDURE | |
| US4127385A (en) | Assay of antibodies with antigen-treated aluminum hydroxide gel | |
| CA2071909A1 (en) | Kit for use in diagnosing maladies | |
| US5536643A (en) | Non-radioactive method for determining circulating red cell volume, total blood volume, and red cell survival | |
| Jayakumar et al. | Identification and analysis of blood group with digital microscope using image processing | |
| Deegan et al. | Antibodies to double-stranded DNA: a comparison of the indirect immunofluorescent test using Crithidia luciliae and the DNA-binding assay | |
| Flesiopoulou et al. | Red Blood Cell Alloantibody Titration-Does the Titration Method Matter? | |
| Adams | Differentiation of myoglobin and hemoglobin in biological fluids | |
| CA1040081A (en) | Method for analysis of endotoxin-precipitated limulus lysate | |
| Copeland et al. | Hemoglobin by first derivative spectrophotometry: extent of hemolysis in plasma and serum collected in vacuum container devices | |
| Raftos et al. | Iron stores assessed in blood donors by hematofluorometry | |
| CA2521486A1 (en) | Method of analysing the cytoskeletal protein of cells | |
| George et al. | Evaluation of two instruments for noninvasive platelet concentrate quality assessment | |
| AU616872B2 (en) | Method and apparatus for measuring the degree of reaction between a foreign entity and a subject's blood cells | |
| EP4368119A1 (en) | Quantitative saliva sample collection tool |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |